Hims & Hers Health Shares Outstanding 2020-2025 | HIMS
Hims & Hers Health shares outstanding history from 2020 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Hims & Hers Health shares outstanding for the quarter ending June 30, 2025 were 0.257B, a 9.36% increase year-over-year.
- Hims & Hers Health 2024 shares outstanding were 0.237B, a 13.12% increase from 2023.
- Hims & Hers Health 2023 shares outstanding were 0.209B, a 2.36% increase from 2022.
- Hims & Hers Health 2022 shares outstanding were 0.205B, a 9.49% increase from 2021.
|
Hims & Hers Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 237 |
| 2023 | 209 |
| 2022 | 205 |
| 2021 | 187 |
| 2020 | 35 |
| 2019 | 35 |
| 2018 | |
|
Hims & Hers Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-06-30 | 257 |
| 2025-03-31 | 247 |
| 2024-12-31 | 237 |
| 2024-09-30 | 235 |
| 2024-06-30 | 235 |
| 2024-03-31 | 229 |
| 2023-12-31 | 209 |
| 2023-09-30 | 210 |
| 2023-06-30 | 208 |
| 2023-03-31 | 207 |
| 2022-12-31 | 205 |
| 2022-09-30 | 205 |
| 2022-06-30 | 204 |
| 2022-03-31 | 203 |
| 2021-12-31 | 187 |
| 2021-09-30 | 200 |
| 2021-06-30 | 192 |
| 2021-03-31 | 153 |
| 2020-12-31 | 35 |
| 2020-09-30 | 36 |
| 2020-06-30 | 35 |
| 2020-03-31 | 35 |
| 2019-12-31 | |
| 2019-09-30 | 5 |
| 2019-06-30 | 5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.049B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $49.025B | 59.82 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $9.874B | 40.87 |
| IRhythm Technologies (IRTC) | United States | $5.681B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.991B | 187.08 |
| Heartflow (HTFL) | United States | $2.850B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.632B | 43.55 |
| 10x Genomics (TXG) | United States | $2.065B | 0.00 |
| Enovis (ENOV) | United States | $1.802B | 9.46 |
| Omnicell (OMCL) | United States | $1.665B | 34.05 |
| Azenta (AZTA) | United States | $1.405B | 61.32 |
| Phreesia (PHR) | United States | $1.363B | 0.00 |
| Schrodinger (SDGR) | United States | $1.347B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.307B | 0.00 |
| Claritev (CTEV) | United States | $0.943B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.877B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.621B | 0.00 |
| Evolent Health (EVH) | United States | $0.592B | 0.00 |
| Talkspace (TALK) | United States | $0.585B | 117.67 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.381B | 0.00 |
| Carlsmed (CARL) | United States | $0.324B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.312B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| CapsoVision (CV) | United States | $0.255B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.192B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.172B | 0.00 |
| CareCloud (CCLD) | United States | $0.140B | 7.70 |
| EUDA Health Holdings (EUDA) | Singapore | $0.116B | 0.00 |
| Outset Medical (OM) | United States | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |